A carregar...
Anti-Angiogenic Agents in Management of Sarcoma Patients: Overview of Published Trials
We reviewed all fully published clinical trials assessing anti-angiogenic agents in sarcoma patients (last issue, January 13, 2020). Anti-angiogenic macromolecules (e.g., bevacizumab or ombrabulin) provide disappointing results. Many multikinase inhibitors have been assessed with non-randomized phas...
Na minha lista:
| Publicado no: | Front Oncol |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Frontiers Media S.A.
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7732617/ https://ncbi.nlm.nih.gov/pubmed/33330082 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.594445 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|